Magdalena Kostrzewa
Via Massarenti 9
Bologna, 40138, Italy
Bologna, 40138, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Implementing cancer prevention in occupational healthcare: initial insights from occupational healthcare staff in Central and Southern Europe - findings from the CPW project.
Journal: BMC cancer
Published: October 13, 2025
Expanding Cancer Prevention: Strategies Integrated into Occupational Health Surveillance.
Journal: Cancers
Published: September 03, 2025
Cancer Prevention at Work (CPW) project: Rationale, framework and research protocol.
Journal: PloS one
Published: August 14, 2025
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo.
Journal: ACS chemical neuroscience
Published: February 19, 2024
Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone.
Journal: European journal of medicinal chemistry
Published: January 08, 2024
Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome.
Journal: Molecular autism
Published: December 02, 2023
Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor.
Journal: Molecules (Basel, Switzerland)
Published: May 27, 2023
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase.
Journal: Journal of medicinal chemistry
Published: December 21, 2022
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R).
Journal: European journal of medicinal chemistry
Published: November 30, 2022
N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation.
Journal: Molecules (Basel, Switzerland)
Published: November 03, 2022
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer.
Journal: Pharmacological research
Published: October 24, 2022
Last Updated: 09/26/2026